Detailed Narrative
Q3 FY25 Performance Overview
Max Healthcare reported a robust Q3 FY25, achieving over 30% year-on-year growth across key parameters including revenue, EBITDA, and occupied bed days. Network gross revenue reached Rs. 2,381 crores, a 34% increase YoY, while network operating EBITDA grew 32% YoY to Rs. 622 crores, resulting in a 27.3% margin. Profit after tax (before exceptional item📎s) also saw a 15% YoY growth to Rs. 390 crores. The company's average occupancy stood at 75%, up from 73% in Q3 last year, with occupied bed days growing 36% YoY.
New Unit Performance and Integration
The company's recent acquisitions and greenfield projects significantly contributed to growth. The new greenfield hospital in Dwarka achieved EBITDA breakeven in December 2024, a record 6 months from its launch, reporting Rs. 59 crores in revenue and an EBITDA loss of Rs. 5 crores for the quarter. Max Lucknow demonstrated strong performance with 58% YoY revenue growth and 94% YoY EBITDA growth, while Jaypee Noida, now a wholly-owned subsidiary, contributed Rs. 112 crores in gross revenue and Rs. 23 crores in operating EBITDA at a 21% margin. These new units collectively reported a gross revenue of Rs. 323 crores in Q3.
Strategic Expansion and Asset-Light Model
Max Healthcare is expanding its footprint with a new 500-bed asset-light 'built-to-suit' hospital in Thane, expected to be commissioned in 2028, marking its third such transaction. This model aims to drive future growth and maximize return on capital employed (ROCE) with minimal investment, targeting a 35% stable state ROCE for the hospital and effectively over 100% for Max Healthcare. The company also approved enhancing the capacity of its upcoming Mohali (Zirakpur) hospital to 400 beds from the previously planned 250 beds.
Capacity Expansion Projects Update
Several capacity expansion projects are progressing on schedule. Max Lucknow will add 140 beds almost immediately, with 64 beds commissioned in January and another 64 in February 2025. Nanavati's Phase 1 (268 beds) is expected to complete within 3-4 months, and Max Smart (Saket Complex) (400 beds) is on track for completion in Q1 FY26. The first phase of 300 beds at Sector-56 Gurgaon is anticipated by the end of Q3 FY26. However, the 550-bed Max Vikrant (Saket Complex) project faces delays due to pending forest approval.
Payor Mix and Pricing Dynamics
The company expects a price increase on the institutional side within one to two months, which is considered long overdue. Management noted that the gap between cash rates and institutional rates has narrowed from 44% to 36%, with expectations for better rates from CGHS. For insurance, price adjustments occur on a rolling basis every two years, typically yielding a 12-13% increase, reflecting an annual medical inflation of about 6%. Management also clarified that the IRDAI guidance on senior citizen insurance policy price hikes is not expected to negatively impact rate negotiations.
PHF Profitability and Operational Efficiency
Max Healthcare's strategic business units, Max@Home and Max Lab, continued to report significant growth, with Max@Home's top line growing 24% YoY to Rs. 55 crores and Max Lab's gross revenue increasing 22% YoY to Rs. 41 crores. The company also discussed the profitability of its Partner Healthcare Facilities (PHFs), noting that fee structures are revised every two years. Donations from PHFs to other trusts are part of their objective clauses and do not impact the company's tax status, with any upstreamed funds subject to a 25% tax.